TFDA-2024-0071-V471
Type IB variation for application TFDA-2024-0071. Type IB variation: New Dosage Strength for Lorlatenilib — major revision
Variation Number
TFDA-2024-0071-V471
Type
Type IB
Application
Change
Status
Submitted
Fee
€4,499
Submitted
2024-01-14
Approved
—
Description
Type IB variation: New Dosage Strength for Lorlatenilib — major revision